Explore / Clinical trial
Clinical trial

Mood and Cognitive Effects of Psilocybin in Healthy Participants

Optimi Health CorporationWithdrawnEarly Phase 1Started Jan 1, 20230 enrolledNCT05252598

Abstract

This study is seeking to find the optimal microdose or low dose of psilocybin (magic mushrooms) that provides general enhancements to mood, memory, sleep, and other measures of general well-being without any hallucinogenic effects.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAnxiety

Keywords

Magic MushroomsMicrodoseMoodSleepCognitionMood DisturbanceMood ChangeSleep DisturbanceDrug EffectPsychedelic ExperiencesHealth, SubjectivePsilocin ToxicityPsilocybin ToxicityPsilocybin Causing Adverse Effects in Therapeutic Use

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.